Treating brain tumors with PDE4 inhibitors.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  TIPS - Trends in Pharmacological Sciences

• Publication date

  2011-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.tips.2011.02.015PMID 21450351PMCID PMC3106141
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The chemokine network, a newly discovered target in high grade gliomas.

  2011cited by this paper
• Medulloblastoma comprises four distinct molecular variants.

  2011cited by this paper
• Targeting cancer with phosphodiesterase inhibitors

  2010cited by this paper
• Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety

  2010cited by this paper
• BDNF and PDE4, but not the GRPR, Regulate Viability of Human Medulloblastoma Cells

  2010cited by this paper
• Expression and role of phosphodiesterase 5 in human malignant melanoma cell line.

  2010cited by this paper
• Adenosine A2A receptor agonists and PDE inhibitors: a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignancies.

  2010cited by this paper
• Induction of cell cycle arrest at G1 and S phases and cAMP-dependent differentiation in C6 glioma by low concentration of cycloheximide

  2010cited by this paper
• Adenosine A 2 A receptor agonists and PDE inhibitors : a synergistic multitarget mechanism discovered through systematic combination screening in B-cell malignancies

  2010cited by this paper
• Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown.

  2010cited by this paper
• Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.

  2010cited by this paper
• Cyclic nucleotide phosphodiesterases (PDE) and peptide motifs.

  2010cited by this paper
• Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9.

  2010cited by this paper
• Chemokines and glioma: invasion and more.

  2010cited by this paper
• Intrinsic sex-specific differences in microvascular endothelial cell phosphodiesterases.

  2010cited by this paper
• A new therapeutic strategy against cancer: cAMP elevating drugs and leptin

  2009cited by this paper
• Phosphodiesterases in the central nervous system.

  2009cited by this paper
• PDE4 inhibitors - a review of the current field.

  2009cited by this paper
• New selective phosphodiesterase 4D inhibitors differently acting on long, short, and supershort isoforms.

  2009cited by this paper
• Chronic Lymphocytic Leukemia and B and T Cells Differ in Their Response to Cyclic Nucleotide Phosphodiesterase Inhibitors1

  2009cited by this paper
• Differential function of phosphodiesterase families in the brain: gaining insights through the use of genetically modified animals.

  2009cited by this paper
• Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs.

  2009cited by this paper
• PET Measurement of the In Vivo Affinity of 11C-(R)-Rolipram and the Density of Its Target, Phosphodiesterase-4, in the Brains of Conscious and Anesthetized Rats

  2009cited by this paper
• Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma.

  2009cited by this paper
• Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood—brain barrier disruption in multiple sclerosis

  2009cited by this paper
• Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty transposon-based somatic mutagenesis screen.

  2009cited by this paper
• Identification of secreted proteins regulated by cAMP in glioblastoma cells using glycopeptide capture and label‐free quantification

  2009cited by this paper
• Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies

  2009cited by this paper
• Lot1 Is a Key Element of the Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)/Cyclic AMP Pathway That Negatively Regulates Neuronal Precursor Proliferation*

  2009cited by this paper
• Preferential Expression of Chemokine Receptor CXCR4 by Highly Malignant Human Gliomas and Its Association with Poor Patient Survival.

  2008cited by this paper
• Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia

  2008cited by this paper
• Targeted Inhibition of Cyclic AMP Phosphodiesterase-4 Promotes Brain Tumor Regression

  2008cited by this paper
• The Role of Phosphodiesterases in Schizophrenia

  2008cited by this paper
• Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells.

  2008cited by this paper
• Physiological Roles for G Protein-Regulated Adenylyl Cyclase Isoforms: Insights from Knockout and Overexpression Studies

  2008cited by this paper
• PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model.

  2008cited by this paper
• Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer's structures.

  2008cited by this paper
• Disruption of the PACAP gene promotes medulloblastoma in ptc1 mutant mice.

  2008cited by this paper
• Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.

  2007cited by this paper
• PREFERENTIAL EXPRESSION OF CHEMOKINE RECEPTOR CXCR4 BY HIGHLY MALIGNANT HUMAN GLIOMAS AND ITS ASSOCIATION WITH POOR PATIENT SURVIVAL

  2007cited by this paper
• Expression of phosphodiesterase 4 is altered in the brains of subjects with autism

  2007cited by this paper
• Chemoresistant KM12C colon cancer cells are addicted to low cyclic AMP levels in a phosphodiesterase 4-regulated compartment via effects on phosphoinositide 3-kinase.

  2007cited by this paper
• Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo.

  2007cited by this paper
• Overview of PDEs and Their Regulation

  2007cited by this paper
• Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling.

  2007cited by this paper
• cAMP phosphodiesterase-4A1 (PDE4A1) has provided the paradigm for the intracellular targeting of phosphodiesterases, a process that underpins compartmentalized cAMP signalling.

  2006cited by this paper
• Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use

  2006cited by this paper
• Molecular details of cAMP generation in mammalian cells: a tale of two systems.

  2006cited by this paper
• Insulin‐like growth factor binding protein‐4 (IGFBP‐4) is a novel anti‐angiogenic and anti‐tumorigenic mediator secreted by dibutyryl cyclic AMP (dB‐cAMP)‐differentiated glioblastoma cells

  2006cited by this paper
• Comprehensive analysis of the expression patterns of the adenylate cyclase gene family in the developing and adult mouse brain

  2006cited by this paper
• Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas

  2006cited by this paper
• Cyclic AMP-mediated Regulation of Transcription Factor Lot1 Expression in Cerebellar Granule Cells*

  2005cited by this paper
• Neuroprotective potential of three neuropeptides PACAP, VIP and PHI.

  2005cited by this paper
• Neurofibromatosis type 1 — a model for nervous system tumour formation?

  2005cited by this paper
• 8-Chloro-cyclic AMP-induced growth inhibition and apoptosis is mediated by p38 mitogen-activated protein kinase activation in HL60 cells.

  2005cited by this paper
• Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways

  2005cited by this paper
• Targeted molecular therapy of malignant gliomas

  2005cited by this paper
• Keynote review: phosphodiesterase-4 as a therapeutic target.

  2005cited by this paper
• Cyclic nucleotides in experimental and human brain tumors

  2004cited by this paper
• The Pro-apoptotic Protein Bim Is a Convergence Point for cAMP/Protein Kinase A- and Glucocorticoid-promoted Apoptosis of Lymphoid Cells*

  2004cited by this paper
• Theophylline: mechanism of action and use in asthma and chronic obstructive pulmonary disease.

  2004cited by this paper
• Adverse drug reactions: A broader perspective

  2004cited by this paper
• A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors

  2003cited by this paper
• ΔRaf-1:ER* Bypasses the Cyclic AMP Block of Extracellular Signal-Regulated Kinase 1 and 2 Activation but Not CDK2 Activation or Cell Cycle Reentry

  2003cited by this paper
• TAPAS-1, a Novel Microdomain within the Unique N-terminal Region of the PDE4A1 cAMP-specific Phosphodiesterase That Allows Rapid, Ca2+-triggered Membrane Association with Selectivity for Interaction with Phosphatidic Acid*

  2002cited by this paper
• The Type IV Phosphodiesterase Inhibitor Rolipram Induces Expression Inhibitors p21Cip1 and p27Kip1, Resulting in Growth Inhibition, Increased Differentiation, and Subsequent Apoptosis of Malignant A-172 Glioma Cells

  2002cited by this paper
• Cranial radiation and concomitant cisplatin and mitomycin-C plus resistance modulators for malignant gliomas

  1997cited by this paper
• Role of conserved histidines in catalytic activity and inhibitor binding of human recombinant phosphodiesterase 4A.

  1997cited by this paper
• Theophylline revisited

  1995cited by this paper
• Inhibition of G1 cyclin expression and G1 cyclin-dependent protein kinases by cAMP in an astrocytic cell line.

  1994cited by this paper
• Cyclic AMP and adenyl cyclase in brain tumors.

  1977cited by this paper
• A – Biochemistry and Physiology

  1974cited by this paper
• [Nobel prize in physiology or medicine 1971: the action of hormones outlined].

  1971cited by this paper

• COMPARATIVE STUDY OF ANTI-CANCER ACTIVITY OF APREMILAST AND IMATINIB – IN VITRO STUDY OF COLON CANCER

  2025cites this paper
• Coronin 1 Loss in Tumor Cells of Glioblastoma Patients Leads to Enhanced Tumor Aggressiveness

  2025cites this paper
• PDE10A as a novel diagnostic and therapeutic target in cancer: insights and challenges

  2025cites this paper
• A New Adjuvant Treatment for Glioblastoma Using Aprepitant, Vortioxetine, Roflumilast and Olanzapine: The AVRO Regimen

  2025cites this paper
• The phosphodiesterase-4 inhibitor Zl-n-91 suppresses glioblastoma growth via EGR1/PTEN/AKT pathway.

  2024cites this paper
• Visualization and bibliometric analysis of cAMP signaling system research trends and hotspots in cancer

  2021cites this paper
• Understanding and exploiting cell signalling convergence nodes and pathway cross-talk in malignant brain cancer.

  2019cites this paper
• Neuroprotective potential of phytochemicals via in silico molecular docking techniques

  2019cites this paper
• Modifying the core ring structure of noscapine in the search for novel anticancer agents

  2019cites this paper
• Targeting Cyclic AMP Signalling in Hepatocellular Carcinoma

  2019cites this paper
• Rolipram optimizes therapeutic effect of bevacizumab by enhancing proapoptotic, antiproliferative signals in a glioblastoma heterotopic model.

  2019cites this paper
• Elevated intracellular cAMP concentration mediates growth suppression in glioma cells

  2019cites this paper
• Emerging therapeutic potential of anti-psychotic drugs in the management of human glioma: A comprehensive review

  2019cites this paper
• Therapeutic opportunities in colon cancer: Focus on phosphodiesterase inhibitors.

  2019cites this paper
• Unstructured Formulation Data Analysis for the Optimization of Lipid Nanoparticle Drug Delivery Vehicles

  2018cites this paper
• Inhibitors of phosphodiesterase as cancer therapeutics.

  2018cites this paper
• Quo natas, Danio?—Recent Progress in Modeling Cancer in Zebrafish

  2017cites this paper
• Apremilast Induces Apoptosis of Human Colorectal Cancer Cells with Mutant KRAS.

  2017cites this paper
• Increase of Intracellular Cyclic AMP by PDE4 Inhibitors Affects HepG2 Cell Cycle Progression and Survival

  2017cites this paper
• The Role of Protein Kinase B Signaling Pathway in Anti-Cancer Effect of Rolipram on Glioblastoma Multiforme: An In Vitro Study

  2017cites this paper
• Drotaverine – a Concealed Cytostatic!

  2017cites this paper
• Design, synthesis and biological evaluation of substituted aminopyridazin-3(2H)-ones as G0/G1-phase arresting agents with apoptosis-inducing activities.

  2017cites this paper
• Pyrazolo[1,5-a][1,3,5]triazine based scaffold as purine analogues with diverse biological activity

  2017cites this paper
• Development of anticancer agents targeting the Hedgehog signaling

  2017cites this paper
• Intersections at the crossroads: Neurofibromatosis type 1, cAMP, sex, and glioma risk

  2016cites this paper
• The G protein Gαs acts as a tumor suppressor in sonic hedgehog signaling-driven tumorigenesis

  2016cites this paper
• Psychiatric aspects of phosphodiesterases: An overview

  2015cites this paper
• Targeting brain tumor cAMP: the case for sex-specific therapeutics

  2015cites this paper
• Not so Fast: Co-Requirements for Sonic Hedgehog Induced Brain Tumorigenesis

  2015cites this paper
• A phosphodiesterase 4B-dependent interplay between tumor cells and the microenvironment regulates angiogenesis in B-cell lymphoma

  2015cites this paper
• Identification of CREB as a transcriptional regulator of glioblastoma biology

  2015cites this paper
• An in vivo chemical genetic screen identifies phosphodiesterase 4 as a pharmacological target for hedgehog signaling inhibition.

  2015cites this paper
• The G-protein Alpha Subunit Gsα Is A Tumor Suppressor In Sonic Hedgehog-driven Medulloblastoma

  2014cites this paper
• Theobromine, the Primary Methylxanthine Found in Theobroma cacao, Prevents Malignant Glioblastoma Proliferation by Negatively Regulating Phosphodiesterase-4, Extracellular Signal-regulated Kinase, Akt/mammalian Target of Rapamycin Kinase, and Nuclear Factor-Kappa B

  2014cites this paper
• Role of phosphodiesterase 4-mediated cyclic AMP signaling in pharmacotherapy for substance dependence.

  2014cites this paper
• PDE7B Is a Novel, Prognostically Significant Mediator of Glioblastoma Growth Whose Expression Is Regulated by Endothelial Cells

  2014cites this paper
• 1,3,5-Triazine-based analogues of purine: from isosteres to privileged scaffolds in medicinal chemistry.

  2014cites this paper
• G-Protein Gαs controls medulloblastoma initiation by suppressing sonic hedgehog signaling

  2014cites this paper
• Chronic Exposure to GLP-1 Increases GLP-1 Synthesis and Release in a Pancreatic Alpha Cell Line (α-TC1): Evidence of a Direct Effect of GLP-1 on Pancreatic Alpha Cells

  2014cites this paper
• Resveratrol induces luminal apoptosis of human colorectal cancer HCT116 cells in three-dimensional culture.

  2014cites this paper
• Inflammation and cancer : the role of the human neutrophil

  2014cites this paper
• Targeted activation of PKA and Epac promotes glioblastoma regression in vitro.

  2013cites this paper
• Benzoquinones and terphenyl compounds as phosphodiesterase-4B inhibitors from a fungus of the order Chaetothyriales (MSX 47445).

  2013cites this paper
• Inhibition of Phosphodiesterase-4 (PDE4) activity triggers luminal apoptosis and AKT dephosphorylation in a 3-D colonic-crypt model

  2012cites this paper
• Cyclic AMP, Protein Kinase A, and Phosphodiesterases: Proceedings of an International Workshop

  2012cites this paper
• Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis

  2012cites this paper
• Vinpocetine inhibits breast cancer cells growth in vitro and in vivo

  2012cites this paper
• Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment.

  2011cites this paper
• Mechanism of RAF isoform switching induced by oncogenic RAS in melanoma

  2011cites this paper